STU:T9G (UK)
Â
Registered Shares
€
0.59
(-2.5%)
Nov 29
Business Description
Vidac Pharma Holding PLC
ISIN : GB00BM9XQ619
Share Class Description:
STU:T9G: Registered SharesDescription
Vidac Pharma Holding PLC is a clinical-stage biopharmaceutical company developing first-in-class oncologic and onco-dermatologic therapies. Its drug, VDA-1102, is at the clinical development stage as an ointment for patients with actinic keratosis, an early form of skin cancer, and in a separate trial for an indication of cutaneous T-cell lymphoma (CTCL). A second molecule, VDA-1275, with possible application for a wide range of solid tumors.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | -10.43 | |||||
| Debt-to-Equity | -0.29 | |||||
| Debt-to-EBITDA | -0.24 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.44 | |||||
| 9-Day RSI | 47.75 | |||||
| 14-Day RSI | 49.55 | |||||
| 6-1 Month Momentum % | 242.39 | |||||
| 12-1 Month Momentum % | 28.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.08 | |||||
| Quick Ratio | 0.08 | |||||
| Cash Ratio | 0.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -1.28 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -1575 | |||||
| ROIC % | -540 | |||||
| ROC (Joel Greenblatt) % | -34200 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -23.43 | |||||
| EV-to-Forward-EBIT | -15.72 | |||||
| EV-to-EBITDA | -23.43 | |||||
| EV-to-Forward-EBITDA | -15.72 | |||||
| EV-to-FCF | -29.41 | |||||
| Earnings Yield (Greenblatt) % | -4.26 | |||||
| FCF Yield % | -3.52 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vidac Pharma Holding PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.027 | ||
| Beta | 0 | ||
| Volatility % | 164.72 | ||
| 14-Day RSI | 49.55 | ||
| 14-Day ATR (€) | 0.075428 | ||
| 20-Day SMA (€) | 0.58725 | ||
| 12-1 Month Momentum % | 28.57 | ||
| 52-Week Range (€) | 0.155 - 1.5 | ||
| Shares Outstanding (Mil) | 54.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vidac Pharma Holding PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vidac Pharma Holding PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vidac Pharma Holding PLC Frequently Asked Questions
What is Vidac Pharma Holding PLC(STU:T9G)'s stock price today?
The current price of STU:T9G is €0.59. The 52 week high of STU:T9G is €1.50 and 52 week low is €0.16.
When is next earnings date of Vidac Pharma Holding PLC(STU:T9G)?
The next earnings date of Vidac Pharma Holding PLC(STU:T9G) is .
Does Vidac Pharma Holding PLC(STU:T9G) pay dividends? If so, how much?
Vidac Pharma Holding PLC(STU:T9G) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers